SEC Form 4 · accession 0000914190-18-000568
NEPHROS INC · NEPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Moshe Pinto
Director
Period of report
Dec 14, 2018
Accepted (ET)
Dec 18, 2018 · 5:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001196298
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Dec 14, 2018 | A | 73,343 | $0.00 | A | 229,788 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $0.45 | holding | — | — | — | — | Aug 14, 2025 | Common Stock | 59,155 | 59,155 | D |
| Stock Option (Right to Buy)F2 | $0.40 | holding | — | — | — | — | Aug 24, 2026 | Common Stock | 33,880 | 33,880 | D |
| Stock Option (Right to Buy)F3 | $0.4999 | holding | — | — | — | — | Dec 20, 2027 | Common Stock | 40,284 | 40,284 | D |
Explanation of responses
- F1On December 14, 2018, the Company granted 73,343 shares of restricted stock of the Company (the "Restricted Stock") in lieu of cash fees payable to Mr. Pinto in respect of his services as a member of the Board of Directors of the Company. The Restricted Stock was granted under the Company's 2015 Equity Incentive Plan (the "2015 Plan"). The Restricted Stock vests 6 months following the grant date.
- F2Fully exercisable.
- F3The option vests as to 13,428 shares on each of 12/20/17, 12/20/18 and 12/20/19.